Myriad Genetics to sell prenatal testing unit to Labcorp for $210 million

Myriad Genetics and Labcorp announced on October 20, 2026 that they had reached a definitive agreement under which Myriad will sell its Prenatal Health testing business, including the Prequel, Foresight, SneakPeek, and FirstGene tests, to Labcorp in exchange for $210 million in cash along with the value of the business's inventory at closing.¹

According to the related 8-K, the companies formalized the deal through an Asset Purchase Agreement dated October 19, 2026, between Myriad Genetics, a Delaware corporation, and Laboratory Corporation of America, also a Delaware corporation.¹ The assets covered include the Foresight Carrier Screen, Prequel Prenatal Screen, FirstGene 4-in-1 Prenatal Screen laboratory developed tests, and the SneakPeek Early Gender Test, with Labcorp assuming certain assets and liabilities tied to that business.¹ Labcorp also agreed to extend job offers to certain employees of the business on terms comparable to their current employment.¹

Labcorp said it expects the acquisition to contribute roughly $160 million in revenue during the first year, with a slightly positive effect on adjusted earnings in year one, and margins reaching the average for its diagnostics segment by the end of year two once integration is complete.¹ Myriad noted that over the prior twelve months, its Prenatal Health portfolio had been used by thousands of providers and more than 600,000 patients.¹

The transaction still requires regulatory clearance and other customary closing conditions, with completion expected by early 2027.¹ The agreement can be terminated by either party if the deal has not closed by February 19, 2027, though that deadline can be automatically extended to October 19, 2027 if only regulatory approvals remain outstanding.¹ Under certain conditions, Labcorp could owe Myriad a $10,500,000 termination fee if the deal fails due to lack of regulatory clearance.¹

Myriad said it would discuss the transaction and related organizational changes further during its quarterly earnings call scheduled for November 4, 2026.¹